Finally, using human malignant glioma stem cells (OB1 cell line), we showed that CTGF treatment induced GFAP, CD133, Nestin and inhibited Sox2 expression, suggesting a possible role for CTGF not only during normal brain development but also in the glioma differentiation program. The gene discussed is GFAP; the disease is central nervous system cancer.